How to Prevent Revenue Leakage in Your Health System 

Documentation gaps, coding inaccuracies, and missed DRG opportunities cost the average health system 3-7% of potential reimbursement each year; for an organization with $500 million in net patient revenue, that represents an annual loss of $15-35 million.  

Most prevention efforts target the front or the back end of the revenue cycle; in contrast, the mid-revenue cycle, where the highest-dollar documentation and coding decisions are finalized, receives far less attention. Understanding where leakage concentrates, and when to intervene, is the ideal starting point for any effective revenue integrity strategy. 

This article covers: 

• Where the most significant, preventable leakage occurs in the inpatient mid-revenue cycle 

• Why the pre-bill window is the highest-leverage point for intervention 

• How clinical defensibility protects both revenue and compliance exposure 

• What a sustainable revenue integrity program delivers over time 

Revenue Leakage in the Mid-Revenue Cycle 

Recognize Where Revenue Leaks in the Inpatient Mid-Revenue Cycle 

Revenue leakage is a broad term, but for health systems operating under MS-DRG and APR-DRG reimbursement models, the most preventable and highest-dollar losses concentrate in the mid-revenue cycle: the space between clinical care, CDI review, coding, and final claim submission. 

Five sources drive the majority of mid-revenue cycle leakage: DRG misassignment, missed complication and comorbidity (CC/MCC) capture, medical necessity documentation gaps, payer denial exposure, and inaccurate HCC and risk adjustment coding. These failures don’t always reflect the quality of care delivered: some stem from documentation that doesn’t capture clinical complexity; others stem from coding errors applied to otherwise adequate records. Both result in inaccurate reimbursement. 

Concurrent CDI programs address some of these gaps, but rarely close all of them. The window between final coding and claim submission remains one of the least managed (and most financially consequential) points in the mid-revenue cycle. 

Prioritize the Pre-Bill Window 

Most health systems address leakage either concurrently, through CDI review during the patient stay, or reactively, through appeals after claims are denied. Both approaches leave the period between final coding and claim submission largely unmanaged. 

At that stage, principal and secondary diagnoses, DRG assignment, query opportunities, and payer compliance requirements can all be reviewed and corrected before a claim is filed. Catching discrepancies here eliminates both the downstream cost of rework and the compliance exposure that comes with post-denial corrections. 

Enjoin’s pre-bill chart review combines technology-enabled screening with clinical review and physician validation. EnFORM+ screens 100% of eligible post-discharge charts for potential documentation and coding opportunities. Enjoin’s CCA team then reviews flagged cases and identifies findings for physician validation before recommendations are returned to the client for action before billing. This process has identified $7.1 million in revenue opportunity per 10,000 charts reviewed, with a denial rate below 2% on reviewed cases. 

Apply Clinical Judgment at the Point of Greatest Risk 

While technology can analyze charts and prioritize cases at scale, clinical validation requires a different standard. That distinction carries significant weight for compliance and audit defensibility. 

When a DRG shift or documentation change moves forward without physician-led validation, the health system assumes risk. A finding that lacks clinical grounding is difficult to defend, regardless of how it was identified. 

Enjoin’s physician advisors hold active board certifications and bring peer-to-peer credibility when engaging medical staff on documentation questions. Each case that moves forward must meet one clear threshold: it must be clinically defensible. That standard protects both the revenue captured and the organization’s audit posture. 

This also addresses a concern many executives share: that more intensive pre-bill review will increase compliance risk. The evidence points in the opposite direction: the resulting findings are more accurate, more durable, and better positioned to withstand regulatory scrutiny. 

Build a Revenue Integrity Program That Compounds 

A single chart review recovers revenue; a sustained mid-revenue cycle program goes a step further, building internal capability to prevent future leakage. 

Leading health systems that partner with Enjoin see results across three dimensions: 

• Education: Physician advisors deliver peer-to-peer feedback with continuing education credits, CDI specialists receive query coaching, and coders receive validation guidance. Enjoin has delivered more than 10,000 hours of physician-directed education across the client base. 

• Analytics: Near-real-time dashboards provide visibility into DRG accuracy, coder performance, denial trends, and education engagement. 

• Clinical outcomes: Accurate documentation and coding drive quality measure performance, HCC and risk adjustment accuracy, and value-based care results, not only reimbursement. 

Enjoin clients average a 900% return on investment, supported by $2 billion in revenue recovery and $400 million in revenue protection across the full client base. UNC Health, a 25-year partner, achieved a 52% reduction in quality penalties through a comprehensive CDI and physician advisor program. 

FAQ 

What percentage of revenue do hospitals typically lose to documentation and coding gaps? 

Health systems lose an estimated 3-7% of potential reimbursement annually to documentation gaps, coding inaccuracies, and missed DRG opportunities. For a large health system, this represents tens of millions in revenue from care already delivered but never fully captured at billing. 

How quickly can a health system expect to see returns from a revenue integrity program? 

Meaningful financial returns are typically visible within the first year, depending on program scope and discharge volume. LCMC Health recovered $13 million in previously uncaptured revenue within 12 months of implementing physician-led pre-bill reviews, alongside a nearly 3% increase in case mix index. 

Won’t a more intensive pre-bill chart review increase our compliance risk? 

This is a common concern, and the evidence runs counter to it. Physician-led review validates that every documentation change is grounded in clinical reality before a claim is submitted. Clinically defensible findings are more accurate, more durable, and better positioned to withstand audit scrutiny. The compliance exposure is lower, not higher, when a board-certified physician validates each case. 

What metrics indicate a revenue integrity program is working? 

Key indicators include case mix index trends, denial rates on reviewed cases, coder accuracy scores, CC/MCC capture rates, and measurable revenue lift per discharge. A well-functioning program shows consistent improvement across each of these over time, alongside increasing internal team capability as education takes hold. 

The Bottom Line 

Revenue leakage in health systems is preventable, but preventing it requires addressing the right part of the cycle. Documentation and coding gaps in the mid-revenue cycle represent the most significant, most avoidable losses most health systems face. Addressing them before billing, with clinical judgment at the center, is how leading health systems protect revenue, reduce compliance exposure, and build internal capability that endures. 

Connect with Enjoin to explore a pre-bill chart review for your health system.